Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
20 studies found for:    Pegasus
Show Display Options
Rank Status Study
1 Unknown  Evaluating PEGASUS - a Group Intervention for Young People With an Autism Spectrum Disorder
Condition: Efficacy of PEGASUS
Intervention: Behavioral: PEGASUS
2 Completed
Has Results
PEGASUS CRT Study: Atrial Support Study in Cardiac Resynchronization Therapy
Condition: Heart Failure
Intervention: Device: Atrial support pacing through cardiac resynchronization therapy. Device: RENEWAL family of CRT-D devices
3 Recruiting The Effects of Commercial Air Travel on Patients Suffering From Pulmonary Hypertension
Conditions: Pulmonary Hypertension;   Pulmonary Arterial Hypertension
4 Active, not recruiting Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Blood
Conditions: Trisomy 21;   Trisomy 18;   Trisomy 13
Interventions: Other: Integrated prenatal screening for Down's syndrome;   Other: Serum QUAD Assay for aneuploidy screening;   Other: Semiconductor MPSS NIPT assay using ccfDNA in maternal blood;   Other: Optical-based MPSS NIPT assay using ccfDNA in maternal blood;   Other: Harmony™ Test (Ariosa Diagnostics)
5 Active, not recruiting To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.
Condition: Wet Macular Degeneration
Intervention: Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
6 Not yet recruiting Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Degarelix in combination with radiation therapy;   Drug: approved GnRH agonist in combination with radiation therapy
7 Completed Randomized Study of Integration Success of Osseotite Dental Implants Placed Using Different Insertion Procedures
Conditions: Partial Edentulism;   Tooth Disease
Interventions: Procedure: High torque insertion;   Procedure: Low torque insertion
8 Completed
Has Results
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Conditions: Myocardial Infarction;   Cardiovascular Death;   Atherothrombosis;   Stroke
Interventions: Drug: Ticagrelor 90 mg;   Drug: Ticagrelor 60 mg;   Drug: Ticagrelor Placebo
9 Completed Footwear Minimalism Study
Condition: Healthy Runners
Interventions: Other: Nike Pegasus;   Other: Nike Free 3.0;   Other: Vibram Five Fingers Shoe
10 Completed Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease
Conditions: Chronic Hepatitis C;   End Stage Renal Disease
Interventions: Drug: Peginterferon alfa-2a;   Drug: Interferon alfa-2a
11 Recruiting A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction
Conditions: Myocardial Infarction;   Diabetes Mellitus;   Renal Disease;   Coronary Artery Disease
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
12 Not yet recruiting ADHerence of ticagrelOr in Real World Patients With aCute Coronary Syndrome
Condition: Acute Coronary Syndrome
Intervention: Drug: Ticagrelor
13 Active, not recruiting Alternate Run Study
Condition: Overuse Injury
Interventions: Other: Alternating run training load;   Other: Alternating footwear;   Other: Constant training;   Other: Constant footwear
14 Recruiting Preventive Effects of Ginseng Against Atherosclerosis
Condition: Ischemic Stroke
Interventions: Dietary Supplement: Ginseng;   Dietary Supplement: Placebo
15 Completed HsTnT in Stable Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention: Other: Progress of CHD
16 Terminated
Has Results
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
Conditions: Anaplastic Astrocytoma;   Glioblastoma
Interventions: Drug: trabedersen;   Drug: temozolomide;   Device: Drug delivery system for administration of AP 12009;   Procedure: Placement of Drug Delivery System;   Drug: carmustine;   Drug: lomustine
17 Active, not recruiting Trauma Management Therapy for OEF and OIF Combat Veterans
Conditions: Post-Traumatic Stress Disorder;   Combat Disorders
Interventions: Behavioral: 17 week Exposure Therapy Control Arm;   Behavioral: Trauma Management Therapy;   Behavioral: Intensive 3-Week Trauma Management Therapy
18 Completed
Has Results
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Conditions: Anemia;   Chronic Kidney Disease (CKD)
Interventions: Drug: HX575 epoetin alfa;   Drug: US-licensed epoetin alfa
19 Completed Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus
Conditions: Uremic Pruritus;   Pruritus
Interventions: Drug: nalbuphine HCl ER 60mg BID;   Drug: nalbuphine HCl ER 90mg BID;   Drug: nalbuphine HCl ER 120mg BID
20 Completed Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus
Conditions: Uremic Pruritus;   Pruritus
Interventions: Drug: nalbuphine HCl ER tablets 60 mg BID;   Drug: nalbuphine HCl ER tablets 120mg BID;   Drug: Placebo tablets BID

Study has passed its completion date and status has not been verified in more than two years.